The effect of non-coding DNA variations on P53 and cMYC competitive inhibition at cis-overlapping motifs

Human Molecular Genetics
Katherine KinWalid D Fakhouri

Abstract

Non-coding DNA variations play a critical role in increasing the risk for development of common complex diseases, and account for the majority of SNPs highly associated with cancer. However, it remains a challenge to identify etiologic variants and to predict their pathological effects on target gene expression for clinical purposes. Cis-overlapping motifs (COMs) are elements of enhancer regions that impact gene expression by enabling competitive binding and switching between transcription factors. Mutations within COMs are especially important when the involved transcription factors have opposing effects on gene regulation, like P53 tumor suppressor and cMYC proto-oncogene. In this study, genome-wide analysis of ChIP-seq data from human cancer and mouse embryonic cells identified a significant number of putative regulatory elements with signals for both P53 and cMYC. Each co-occupied element contains, on average, two COMs, and one common SNP every two COMs. Gene ontology of predicted target genes for COMs showed that the majority are involved in DNA damage, apoptosis, cell cycle regulation, and RNA processing. EMSA results showed that both cMYC and P53 bind to cis-overlapping motifs within a ChIP-seq co-occupied region in Chr1...Continue Reading

References

Jun 5, 2002·Genome Research·W James KentDavid Haussler
May 16, 2003·Molecular and Cellular Biology·Yutaka NibuMichael Levine
Dec 19, 2003·Nucleic Acids Research·Donna KarolchikW James Kent
Nov 10, 2006·Proceedings of the National Academy of Sciences of the United States of America·Karen I ZellerChia-Lin Wei
May 14, 2008·Nucleic Acids Research·Leonie SmeenkMarion Lohrum
Oct 17, 2008·Genes & Development·Martin Eilers, Robert N Eisenman
Dec 17, 2008·PloS One·Benjamin L KidderStephen Palmer
Jul 31, 2009·Briefings in Functional Genomics & Proteomics·Douglas J Epstein
Dec 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kyoung-Hwa LeeJing Huang
May 4, 2010·Nature Biotechnology·Cory Y McLeanGill Bejerano
Nov 22, 2011·PloS One·Volkhard SeitzMichael Hummel
Oct 1, 2013·Cell Death and Differentiation·B WangE C Ren
Nov 29, 2013·Nucleic Acids Research·Liyuan GuoJing Wang
Nov 29, 2013·Nucleic Acids Research·Judith A BlakeUNKNOWN Mouse Genome Database Group
Jan 1, 2014·Journal of Dermatological Science·Mitsuha HayashiMayumi Tamari
Jan 21, 2014·Human Molecular Genetics·Walid D FakhouriBrian C Schutte
Feb 4, 2014·Nature Methods·Graham R S RitchiePaul Flicek
Jul 22, 2014·Cell Reports·Gue Su ChangB Franklin Pugh

❮ Previous
Next ❯

Citations

Feb 1, 2017·Radiation Research·Howard B LiebermanConstantinos G Broustas

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.